-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$8.5042.14% Upside
Eton Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Eton Pharmaceuticals, Inc.?
Eton Pharmaceuticals, Inc. has been rated by research analysts at Craig-Hallum, H.C. Wainwright in the past 90 days.